Navigation Links
Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups

CHAPEL HILL, N.C., March 11 /PRNewswire/ -- With patent expiration a looming concern across the bio-pharmaceutical industry, new product commercialization efforts have taken on increased importance. It's against this backdrop that new product planning groups across biopharma are trying to deal more effectively with the twin pressures of meeting timelines and delivering commercial insights.

A recent data-rich benchmarking study from Best Practices, LLC delivers actionable insights on the critical elements of the new product planning (NPP) function. The study, "Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability," identifies the full set of activities that NPP groups perform across the development cycle as well as the structure and roles of NPP groups.

To download a complimentary study excerpt, go to:

The research project illustrated that as companies move through each successive development Phase, the actual nature of assessment activities changes. For instance, many companies stated that competitive assessments and lifecycle planning made in the early stages are somewhat speculative, primarily designed to spot opportunities. Later on these activities become more specific, designed to drive forecasts.

While most companies perform competitive assessments from pre-clinical all the way through Phase 3, study participants said the activity is particularly critical in pre-clinical because:

  • It can gauge what changes will occur in the years ahead
  • It helps with understanding the disease state and where competitors' products fit in
  • It informs how well your drug will fit in the market
  • It helps frame "go, no-go" analysis so that, as data comes in, competitive assessment can drive forecasting and profitability potential
  • The research examines dozens of NPP developmental activities in terms of timing during the development process, intended outcomes and value for the organization.

In addition, the study details the strengths and weaknesses of various NPP organizational structures and how the operational characteristics of the NPP function evolve as a company matures.

To review samples of key metrics and findings in the report, download a complimentary study excerpt at:

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at best-in-class organizations such as Abbott, Astellas, Bayer, Daiichi Sankyo, Eli Lilly, Merck, Novartis, sanofi aventis, Wyeth and others.

To learn more about Best Practices' other timely research visit: or contact Jeff Zimmer at 919-767-9180 or


Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC

Back to top



SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AdMeTech Hails New Research That Shows Promise of MRI to Discriminate Aggressive Prostate Cancer From Dormant Disease
2. Massachusetts Institute of Technology (MIT) to Launch New Brain Research Effort with Acquisition of Elekta MEG Technology
3. Americas Pharmaceutical Research and Biotechnology Companies Lead the Charge Toward Longer, Healthier Lives for Americans
4. AdMeTech Calls for Major Research Commitment to End Prostate Cancer Crisis
5. Researchers Pave Way for Tracking of Prostate Motion With a Single kV Imager During Arc Radiotherapy
6. BNA Books Announces Publication of New 2009 Cumulative Supplement to Pharmaceutical Law: Regulation of Research, Development, and Marketing
7. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
8. AdMeTech to Testify in Congress About Prostate Cancer Crisis, Research to Improve Diagnostic Tools as a Solution
9. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
10. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
11. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
Post Your Comments:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
Breaking Medicine News(10 mins):